With multiple von Willebrand disease therapies approaching clinical trials, columnist Jennifer Lynne is excited about the future of treatment.
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Star Therapeutics, a clinical stage biotechnology company discovering and developing best-in-class antibodies, today announced interim clinical data from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results